Almac Group Announces Acquisition of BioClin Laboratories

Published on: 

Applied Clinical Trials

Almac Group announced the acquisition of 100% shares of BioClin Laboratories. BioClin will bring fourth its expert analytical services and analysis to increase Almac’s capacity and compliment its existing business strategic expansion which will help them to serve clients globally.

Read the full release here.